| Literature DB >> 29766684 |
Meagan Seay1, Janet C Rucker1,2.
Abstract
Neuromyelitis optica (NMO) is an autoimmune, inflammatory demyelinating disorder often leading to severe vision impairment and disability. The discovery of a diagnostic biomarker, the aquaporin-4 antibody (AQP4-IgG), transformed the clinical diagnosis and treatment of NMO and broadened the spectrum of disease [NMO spectrum disorders (NMOSD)]. Though the antibody is highly sensitive and specific to NMOSD, routine testing in patients with typical optic neuritis is considered controversial. This article will provide a brief review of NMOSD and highlight the pros and cons of routine testing in typical optic neuritis. Copyright 2018 Asia-Pacific Academy of Ophthalmology.Entities:
Keywords: NMO; aquaporin-4 immunoglobulin; optic neuritis
Mesh:
Substances:
Year: 2018 PMID: 29766684 DOI: 10.22608/APO.2018170
Source DB: PubMed Journal: Asia Pac J Ophthalmol (Phila) ISSN: 2162-0989